Investor insight: Nano‑X Imaging’s insider RSU grant fuels confidence as its AI‑driven imaging platform gains FDA clearance and expands pharma contracts—watch the 2026‑2027 milestones for upside potential.
Insider Koren Ofir’s RSU buy at Nano‑X signals confidence in its cloud imaging tech amid a steep 88% dip—why investors should watch the February vesting.